These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

199 related items for PubMed ID: 9134271

  • 21. The health benefits of moderate alcohol consumption: a review of the literature.
    Baum-Baicker C.
    Drug Alcohol Depend; 1985 Jun; 15(3):207-27. PubMed ID: 4028954
    [Abstract] [Full Text] [Related]

  • 22. Cardioprotection with alcohol: role of both alcohol and polyphenolic antioxidants.
    Sato M, Maulik N, Das DK.
    Ann N Y Acad Sci; 2002 May; 957():122-35. PubMed ID: 12074967
    [Abstract] [Full Text] [Related]

  • 23. [Hypothetical Alcohol Consumption Interventions and Hepatic Steatosis: A Longitudinal Study in a Large Cohort].
    Zhang N, Zhang Y, Wei J, Xiang Y, Hu Y, Xiao X.
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2024 May 20; 55(3):653-661. PubMed ID: 38948274
    [Abstract] [Full Text] [Related]

  • 24. Grape juice but not orange or grapefruit juice inhibits platelet activity in dogs and monkeys.
    Osman HE, Maalej N, Shanmuganayagam D, Folts JD.
    J Nutr; 1998 Dec 20; 128(12):2307-12. PubMed ID: 9868174
    [Abstract] [Full Text] [Related]

  • 25. Mechanism of cardioprotection by resveratrol, a phenolic antioxidant present in red wine (Review).
    Wu JM, Wang ZR, Hsieh TC, Bruder JL, Zou JG, Huang YZ.
    Int J Mol Med; 2001 Jul 20; 8(1):3-17. PubMed ID: 11408943
    [Abstract] [Full Text] [Related]

  • 26. Effect of red wine and red grape extract on blood lipids, haemostatic factors, and other risk factors for cardiovascular disease.
    Hansen AS, Marckmann P, Dragsted LO, Finné Nielsen IL, Nielsen SE, Grønbaek M.
    Eur J Clin Nutr; 2005 Mar 20; 59(3):449-55. PubMed ID: 15674304
    [Abstract] [Full Text] [Related]

  • 27. Wine and polyphenols related to platelet aggregation and atherothrombosis.
    Ruf JC.
    Drugs Exp Clin Res; 1999 Mar 20; 25(2-3):125-31. PubMed ID: 10370875
    [Abstract] [Full Text] [Related]

  • 28. Potential health benefits from the flavonoids in grape products on vascular disease.
    Folts JD.
    Adv Exp Med Biol; 2002 Mar 20; 505():95-111. PubMed ID: 12083471
    [Abstract] [Full Text] [Related]

  • 29. Red wine, dealcoholized red wine, and especially grape juice, inhibit atherosclerosis in a hamster model.
    Vinson JA, Teufel K, Wu N.
    Atherosclerosis; 2001 May 20; 156(1):67-72. PubMed ID: 11368998
    [Abstract] [Full Text] [Related]

  • 30. Lowering the alcohol content of red wine does not alter its cardioprotective properties.
    Lamont K, Blackhurst D, Albertyn Z, Marais D, Lecour S.
    S Afr Med J; 2012 May 23; 102(6):565-7. PubMed ID: 22668965
    [Abstract] [Full Text] [Related]

  • 31. Does diet or alcohol explain the French paradox?
    Criqui MH, Ringel BL.
    Lancet; 2012 May 23; 344(8939-8940):1719-23. PubMed ID: 7996999
    [Abstract] [Full Text] [Related]

  • 32. [Red wine in medicine: panacea, fashion or ... risk factor?].
    Kwaśniewska M, Kostka T, Drygas W.
    Przegl Lek; 2000 May 23; 57(5):300-4. PubMed ID: 11057122
    [Abstract] [Full Text] [Related]

  • 33. Does white wine qualify for French paradox? Comparison of the cardioprotective effects of red and white wines and their constituents: resveratrol, tyrosol, and hydroxytyrosol.
    Dudley JI, Lekli I, Mukherjee S, Das M, Bertelli AA, Das DK.
    J Agric Food Chem; 2008 Oct 22; 56(20):9362-73. PubMed ID: 18821770
    [Abstract] [Full Text] [Related]

  • 34. Polyphenolic grape extract inhibits platelet activation through PECAM-1: an explanation for the French paradox.
    de Lange DW, Verhoef S, Gorter G, Kraaijenhagen RJ, van de Wiel A, Akkerman JW.
    Alcohol Clin Exp Res; 2007 Aug 22; 31(8):1308-14. PubMed ID: 17559545
    [Abstract] [Full Text] [Related]

  • 35. The relationship between wine consumption and cardiovascular risk: from epidemiological evidence to biological plausibility.
    Rotondo S, Di Castelnuovo A, de Gaetano G.
    Ital Heart J; 2001 Jan 22; 2(1):1-8. PubMed ID: 11214695
    [Abstract] [Full Text] [Related]

  • 36. The red wine hypothesis: from concepts to protective signalling molecules.
    Opie LH, Lecour S.
    Eur Heart J; 2007 Jul 22; 28(14):1683-93. PubMed ID: 17561496
    [Abstract] [Full Text] [Related]

  • 37. Platelet rebound effect of alcohol withdrawal and wine drinking in rats. Relation to tannins and lipid peroxidation.
    Ruf JC, Berger JL, Renaud S.
    Arterioscler Thromb Vasc Biol; 1995 Jan 22; 15(1):140-4. PubMed ID: 7749810
    [Abstract] [Full Text] [Related]

  • 38. The role of alcohol in the anti low density lipoprotein oxidation activity of red wine.
    van Golde PH, Sloots LM, Vermeulen WP, Wielders JP, Hart HC, Bouma BN, van de Wiel A.
    Atherosclerosis; 1999 Dec 22; 147(2):365-70. PubMed ID: 10559522
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Alcohol, wine and platelet function.
    Ruf JC.
    Biol Res; 2004 Dec 22; 37(2):209-15. PubMed ID: 15455649
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.